Directory
>
Jonathan Monteleone
Jonathan Monteleone
Executive Director, CPSS at Alexion, AstraZeneca Rare Disease | Alexion Pharmaceuticals, Inc.
Raleigh, North Carolina, United States
Jonathan Monteleone
Summary
Jonathan Monteleone is a seasoned professional with over 25 years of experience in the biopharmaceutical sector, specializing in quantitative pharmacology and mathematical modeling. Currently serving as the CPSS Lead at Alexion, AstraZeneca Rare Disease, he has a proven track record of leading teams and providing strategic guidance that shapes development programs. Jonathan's expertise spans a wide array of areas including clinical trials, drug development, and regulatory submissions, with a particular focus on rare diseases. His extensive background in pharmacometrics and clinical data management has positioned him as a key player in the industry. He is not only dedicated to advancing therapeutic solutions but also passionate about mentoring the next generation of scientists. Jonathan's work has been recognized in reputable journals, showcasing his contributions to the field. His commitment to innovation and excellence continues to drive his career forward.
Jonathan Monteleone
Work Experience
Executive Director, CPSS at Alexion, AstraZeneca Rare Disease at
Alexion Pharmaceuticals, Inc.
September 2023 - Present
Executive Director, Head of Quantitative Pharmacology at
Alexion Pharmaceuticals, Inc.
August 2022 - October 2023
Senior Director, Head of Quantitative Pharmacology at
Alexion Pharmaceuticals, Inc.
May 2021 - August 2022
Senior Director of Pharmacometrics at
Alexion Pharmaceuticals, Inc.
June 2020 - May 2021
Director of Pharmacometrics at
Alexion Pharmaceuticals, Inc.
September 2016 - June 2020
Associate Director of Pharmacometrics at
Alexion Pharmaceuticals, Inc.
July 2013 - September 2016
Associate Director of Pharmacometrics at
Pharsight
April 2013 - June 2013
Senior consultant at
Pharsight
August 2007 - March 2013
Pharmacometrician at
DOV Pharmaceutical
March 2005 - June 2007
Frequently Asked Questions about Jonathan Monteleone
What is Jonathan Monteleone email address?
Jonathan Monteleone's primary email address is ***********@alxn.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jonathan Monteleone work for?
Jonathan Monteleone is a Executive Director, CPSS at Alexion, AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc., a company specializing in Commercial physical research.
How can I directly contact Jonathan Monteleone?
To contact Jonathan Monteleone directly, you can use the email address ***********@alxn.com. Complete contact information is available upon registration with Muraena.
Who is Jonathan Monteleone?
Jonathan Monteleone is a seasoned professional with over 25 years of experience in the biopharmaceutical sector, specializing in quantitative pharmacology and mathematical modeling. Currently serving as the CPSS Lead at Alexion, AstraZeneca Rare Disease, he has a proven track record of leading teams and providing strategic guidance that shapes development programs. Jonathan's expertise spans a wide array of areas including clinical trials, drug development, and regulatory submissions, with a particular focus on rare diseases. His extensive background in pharmacometrics and clinical data management has positioned him as a key player in the industry. He is not only dedicated to advancing therapeutic solutions but also passionate about mentoring the next generation of scientists. Jonathan's work has been recognized in reputable journals, showcasing his contributions to the field. His commitment to innovation and excellence continues to drive his career forward.
Jonathan`s contact details
***********@alxn.com
*******************@alexion.com
Colleagues
Executive Director
VP, Global Head of Country Operations
President
Chief Operating Officer
Business Operations Lead, Chief of Staff to Alexion CEO & AstraZeneca Chief Strategy Officer
Executive Director, TA Lead, Global Regulatory Affairs
Executive Director
Executive Director, Clinical Operations Late Phase TA Lead
SVP, Strategy and Business Development
SVP, Head of Development, Regulatory and Safety